Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,949,031
-
Share change
-
-3,852,861
-
Total reported value
-
$14,827,364
-
Put/Call ratio
-
38%
-
Price per share
-
$0.45
-
Number of holders
-
59
-
Value change
-
-$4,282,992
-
Number of buys
-
22
-
Number of sells
-
29
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q4 2022
As of 31 Dec 2022,
LEAP THERAPEUTICS INC - COM (LPTX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,949,031 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Artal Group S.A., Rock Springs Capital Management LP, VANGUARD GROUP INC, 683 Capital Management, LLC, Key Client Fiduciary Advisors, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, ELEMENT CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.